Drugs Targeted for Price Cutting in Japan: The Case of Price Revisions Based on the Divergence of Official Versus Delivery Prices

Social Sciences

• Japan 76%
• drug 70%
• patent 15%
• determinants 7%
• market 6%
• follower 5%
• sales 5%
• reconstruction 4%
• regression analysis 4%
• logistics 4%
• regression 3%
• costs 3%

Medicine & Life Sciences

• Japan 86%
• Pharmaceutical Preparations 43%
• Generic Drugs 7%
• Linear Models 4%
• Regression Analysis 3%
• Logistic Models 3%
• Costs and Cost Analysis 3%